Loading organizations...
Loading organizations...
IP Infusion has raised $17.0M across 2 funding rounds.
Key people at IP Infusion.
IP Infusion has raised $17.0M in total across 2 funding rounds.
IP Infusion develops disaggregated networking solutions, providing network operating systems and management platforms that decouple hardware from software. Their primary products, OcNOS and IP Maestro, offer network operators increased flexibility, reduced operational costs, and accelerated innovation. These solutions cater to diverse networking environments including service provider, data center, access, and aggregation, enabling a more open and programmable network infrastructure.
The company was founded in 1999 by Yoshinari Yoshikawa and Kunihiro Ishiguro. Their vision stemmed from the insight that traditional monolithic networking systems hindered innovation and efficiency. They aimed to address this by pioneering the separation of network software from proprietary hardware, thereby laying the groundwork for open networking principles that empower greater customization and control for network operators.
IP Infusion's offerings are utilized by carriers, service providers, and data center operators seeking adaptable network architectures. The company envisions a future where network infrastructure is inherently open and programmable, allowing organizations to rapidly deploy new services and respond to evolving market demands without vendor lock-in. They continue to focus on delivering robust, software-centric networking solutions that redefine infrastructure capabilities.
# IP Infusion: High-Level Overview
IP Infusion is a network operating systems provider that enables disaggregated networking—allowing carriers, service providers, and data center operators to build networks using low-cost commodity hardware instead of proprietary vendor systems.[1][3] The company delivers OcNOS (Open Compute Network Operating System), a carrier-grade, hardware-independent software platform that serves over 350 customers worldwide, including major networking equipment manufacturers.[1][5]
The company solves a critical industry problem: vendor lock-in and high total cost of ownership in networking infrastructure. By providing open standards-based software that runs on any hardware, IP Infusion enables operators to reduce capital and operational expenses while gaining flexibility to deploy new services rapidly.[3] This approach has proven particularly valuable as networks scale to support AI/ML workloads, 5G, and cloud computing, where traditional proprietary networking equipment becomes prohibitively expensive.
# Origin Story
IP Infusion was founded in 1999 by Kunihiro Ishiguro and Yoshinari Yoshikawa with a prescient vision: that software, not hardware, would define modern networking.[2] The company's roots trace to the open-source GNU Zebra project, which the founders commercialized into ZebOS, their first product that became wildly popular among networking vendors for its portability and customizability.[3]
The company's trajectory shifted significantly in 2006 when ACCESS CO., LTD. acquired IP Infusion, transforming it into a wholly owned but independently operated subsidiary.[2] This acquisition provided capital and stability while preserving the company's focus on open networking innovation. Over the following two decades, IP Infusion evolved from a ZebOS provider into a comprehensive platform company, eventually launching OcNOS as its flagship product—a more advanced, carrier-grade evolution of its original software.[3] The company has since expanded to three continents with R&D centers including one in Gatineau, Quebec, and approximately 300-805 employees globally.[2][5]
# Core Differentiators
# Role in the Broader Tech Landscape
IP Infusion sits at the intersection of two powerful industry trends: network disaggregation and cost optimization under scale pressure. As service providers and carriers face mounting pressure to reduce capital expenditure while supporting exponential data growth, the traditional model of buying integrated hardware-software systems from single vendors has become economically untenable.
The company's timing is particularly advantageous given the rise of AI/ML workloads, which demand massive, flexible networking fabrics that proprietary systems struggle to provide cost-effectively. By enabling operators to build networks from commodity components running open software, IP Infusion addresses a fundamental shift in how infrastructure is architected. Their leadership in standards bodies like TIP and participation in initiatives like O-RAN Plugfest positions them as architects of the open networking future rather than mere vendors.[5]
The broader ecosystem benefits from IP Infusion's work: their solutions reduce barriers to entry for new networking equipment manufacturers, accelerate innovation cycles, and create competitive pressure on legacy vendors to adopt more open approaches. This democratization of networking software has ripple effects across the entire technology stack.
# Quick Take & Future Outlook
IP Infusion is well-positioned to capture significant value as network disaggregation transitions from niche adoption to industry standard. The company's expansion into AI/ML networking (launched mid-2025) signals strategic foresight—recognizing that the next wave of infrastructure investment will prioritize performance and cost efficiency in ways that only open, flexible platforms can deliver.
The key question ahead is whether IP Infusion can maintain its independence and innovation velocity as a subsidiary of ACCESS while competing against both legacy vendors (who are slowly embracing openness) and emerging open-source alternatives. Their 25-year track record, 350+ customer base, and recent product launches suggest they've built defensible moats through depth of features, reliability, and customer relationships. As networks become increasingly software-defined and cost-conscious, IP Infusion's core thesis—that open standards and commodity hardware are superior to proprietary lock-in—appears vindicated by market forces.
Key people at IP Infusion.
IP Infusion has raised $17.0M in total across 2 funding rounds.
IP Infusion has raised $17.0M across 2 funding rounds. Most recently, it raised $15.0M Series C in April 2002.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 1, 2002 | $15.0M Series C | ||
| Jan 1, 2000 | $2.0M Series B |
